Get startedLog in
    Picture of Knight Therapeutics logo

    GUD — Knight Therapeutics News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareBalancedMid CapNeutral
    All News

    Brief: Brazil's Biotoscana Appoints Claudio Coracini As Interim CEO After Agreement To Sell Control To Knight Therapeutics- Filing

    Picture of Knight Therapeutics logoKnight Therapeutics
    28/10/2019 16:08
    Oct 28 (Reuters) - Biotoscana Investments SA  GBIO33.SA :
    * BRAZIL'S BIOTOSCANA APPOINTS CLAUDIO CORACINI AS INTERIM
CEO
AFTER AGREEMENT TO SELL CONTROL TO KNIGHT THERAPEUTICS- FILING

Source text for Eikon:  ID: 
Further company coverage:  GBIO33.SA 

 (Reporting by Tatiana Bautzer)
 ((Tatiana.Bautzer@thomsonreuters.com; Reuters Messaging:
tatiana.bautzer.thomsonreuters.com@reuters.net))

    Recent news on Knight Therapeutics

    See all news